Oxymorphone hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0115-1317 -
Package NDC
0115-1317-01 -
Package NDC
0115-1317-03 -
Package NDC
0115-1317-08 -
Package NDC
0115-1317-13 -
Application number
ANDA079087 -
SPL ID
a8dc6624-df1e-4e5a-b445-9541658e3430 -
SPL set ID
557e9610-62d7-42bf-90c1-44215bd8c1f8 -
UNII
5Y2EI94NBC -
RxCUI
977874 -
RxCUI
977894 -
RxCUI
977902 -
RxCUI
977909 -
RxCUI
977915 -
RxCUI
977923 -
RxCUI
977929
What the source publishes
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Active ingredients
- Oxymorphone hydrochloride
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Oxymorphone hydrochloride",
"splId": "a8dc6624-df1e-4e5a-b445-9541658e3430",
"labels": [
{
"setId": "557e9610-62d7-42bf-90c1-44215bd8c1f8",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=557e9610-62d7-42bf-90c1-44215bd8c1f8",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=557e9610-62d7-42bf-90c1-44215bd8c1f8"
}
],
"routes": [
"ORAL"
],
"labeler": "Amneal Pharmaceuticals of New York LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1317-01)",
"package_ndc": "0115-1317-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20130102"
},
{
"sample": false,
"description": "1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1317-03)",
"package_ndc": "0115-1317-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20130102"
},
{
"sample": false,
"description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1317-08)",
"package_ndc": "0115-1317-08",
"identifierStatus": "well-formed",
"marketing_start_date": "20130102"
},
{
"sample": false,
"description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1317-13)",
"package_ndc": "0115-1317-13",
"identifierStatus": "well-formed",
"marketing_start_date": "20130102"
}
],
"productId": "0115-1317_a8dc6624-df1e-4e5a-b445-9541658e3430",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED, EXTENDED RELEASE",
"productNdc": "0115-1317",
"deaSchedule": "CII",
"genericName": "Oxymorphone hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "OXYMORPHONE HYDROCHLORIDE",
"strength": "30 mg/1"
}
],
"applicationNumber": "ANDA079087",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20130102",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"5Y2EI94NBC"
],
"rxcui": [
"977874",
"977894",
"977902",
"977909",
"977915",
"977923",
"977929"
],
"spl_set_id": [
"557e9610-62d7-42bf-90c1-44215bd8c1f8"
],
"manufacturer_name": [
"Amneal Pharmaceuticals of New York LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0115-1317_a8dc6624-df1e-4e5a-b445-9541658e3430"